Drug
mogamulizumab-kpkc
Marketed as POTELIGEO.
Generic name
mogamulizumab-kpkc
Brand names
POTELIGEO
First FDA approval
2018-08-08
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761051 | POTELIGEO | 2018-08-08 | KYOWA KIRIN |
Manufacturers
KYOWA KIRIN
Frequently asked questions
When was mogamulizumab-kpkc FDA approved?
Earliest FDA approval on record: 2018-08-08.
What brand names are sold as mogamulizumab-kpkc?
POTELIGEO.
Sources
Appeal a mogamulizumab-kpkc denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com